Dong-ki Lee

Dong-ki Lee

Company: OliX Pharmaceuticals

Job title: Founder & Chief Executive Officer


Asymmetric siRNA Therapeutics Targeting Skin, Eye, & Liver Diseases 11:00 am

RNAi therapeutics have the potential to target hepatic as well as extra-hepatic diseases with the use of optimal delivery methods. We have established lipid-conjugated asymmetric siRNA (asiRNA) targeting skin and ocular tissues to develop therapeutic programs against the hypertrophic scar, androgenic alopecia, and age-related macular degeneration. We also present a GalNAc-based liver targeting strategy to…Read more

day: Pre-Conference Day

A Hanson Wade Group Company

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.